Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.
about
Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeuticStructure-based prediction of asparagine and aspartate degradation sites in antibody variable regionsAn overview of APP processing enzymes and products.Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms.Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's diseaseAlternative pathways for production of beta-amyloid peptides of Alzheimer's disease.Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.Intracellular trafficking of the β-secretase and processing of amyloid precursor protein.The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation.Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry.APP/Aβ structural diversity and Alzheimer's disease pathogenesis.Cathepsins S, B and L with aminopeptidases display β-secretase activity associated with the pathogenesis of Alzheimer's disease.
P2860
Q28235248-C5ABB143-90DE-4D66-8203-0A9030B64F15Q28539968-8F224FC5-F2DF-4259-B2A0-4ED3AEFCAE36Q33927819-FE2EEC84-6691-4065-9686-AF23AB590DBBQ34110227-408E78D0-B498-4BC2-9212-9FF0BB62F993Q34695506-CD8E4137-0D24-4F89-8D46-92191CE67FDDQ35596997-093F2984-35A3-4F32-A463-45F93CBC10F3Q37124928-97BF58C1-7857-425A-B177-3737B847F0F4Q37763948-EBFC0A08-76EB-4418-ACB0-E995262B69F4Q37915426-3CE62248-E53F-4455-9DF6-5FEA3BB5DFD5Q39937281-2480F0AE-8F28-48B8-859D-587DCAB9A8D4Q41970463-C8087EF9-6AA8-41E0-B511-0EBA08F4359EQ46320596-1B9360E2-2803-41C7-B4C2-A5515D272692Q53319143-F6803DAB-FE3E-47CF-8220-F654A8F5655D
P2860
Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@ast
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@en
type
label
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@ast
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@en
prefLabel
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@ast
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@en
P2093
P2860
P356
P1433
P1476
Isoaspartate-containing amyloi ...... of potential beta-secretases.
@en
P2093
Hans-Ulrich Demuth
Livia Böhme
Susanne Manhart
Torsten Hoffmann
P2860
P304
P356
10.1515/BC.2008.125
P577
2008-08-01T00:00:00Z